1380 St. Lidwina born in Holland; her progressive illnesssuggests a diagnosis of MS
1794 Birth of Augustus d'Este, an early case of what wouldlater be known as MS
1838 Robert Carswell includes an illustration of a case of"a peculiar disease state," showing the features of MS
1868 Jean-Martin Charcot gives three lectures describing thefeatures of MS and names it "sclérose en plaque disseminée"
1873-1875 A series of cases are published in London by WilliamMoxom
1884-1887 Numerous lectures and published case reports; opticneuritis andmyelitis described (1884); infection suggested as a cause (1884);family with 12 cases of MS described (1885); toxins suggested as a cause (1887)
1891 The lumbar puncture technique is developed
1899 Oligodendrocytes (cells that produce and maintain myelin)are described
1906 A toxin tomyelin is suggested for the breakdown of myelinin plaques
1915 James Dawson publishes his major work on the pathology ofthe MS plaque
1933 Animal model of MS (EAE) is developed; folding wheelchairinvented by Everest, allowing individuals with disabilities to travel by carand bring their wheelchair
1950 Roy Swank develops lowfat diet for individuals with MS;first major study conducted in the US and Canada, funded by NMSS
1951 First use of Cortisone to treat MS
1955 Kutzke defines Disability Status Scale
1957 Interferons are discovered
1965 The initial criteria for diagnosis of MS is described
1968 Thieme develops the electric mobility scooter
1970 Acute MS flare-ups are treated with adrenocorticotropin
1972 McDonald and Halliday show that conduction is slowed orblocked along demyelinated nerves and use evoked potential methods with MS
1977 Jacobs gives interferon to MS patients intrathecally;McDonald and Halliday outline new diagnostic criteria for MS; oral baclofenapproved to treat spasticity
1978 Patterns of myelin repair are demonstrated by Prineas
1980s-1990s Tegretol® is used to treat pain; Ditropan® is used totreat spastic bladder; as with most symptom management drugs, these areprescribed off-label
1981 First MRI scan of the brain is performed and first MRIimages of MS lesions produced; Jacobs reports reduced exacerbations withintrathecal interferon
1983 Poser criteria described for MS; Epstein-Barr virussuspected of being involved with MS; Kurtzke introduces Expanded DisabilityStatus Scale (EDSS)
1987 Prozac® is approved to treat depression; first SSRIantidepressant
1988 Medtronic® Synchromed™ pump and infusion system(implanted and programmable) receives premarket approval
1990 Americans with Disabilities Act signed into law
1990s Amantidine is used to treat fatigue
1993 Betaseron® approved; Neurontin® approved to treat pain
1995 Copaxone® approved
1996 Avonex® approved
1998 Provigil® approved to treat fatigue; Viagra® approved totreat sexual dysfunction
2000 Novantrone® approved
2002 Rebif® approved; Zanaflex® approved to treat spasticityin MS
2006 Tysabri® approved
2010 Extavia® approved; Gilenya™ approved; Botox® injectionapproved for adult upper-limb spasticity; Nuedexta™ approved for the treatmentof pseudobulbar affect (PBA); Ampyra™ approved to improve walking inindividuals with MS
2011 Botox® injection approved for urinary incontinence inindividuals with MS
2012 Aubagio® approved
THE FUTURE Possible approvals of Dimethyl Fumarate (DMF); Lemtrada™;ocrelizumab; daclizumab; Tovaxin®; laquinimod; and many more!
If you would like, you can comment to our blog posts LIKE this Blog by clicking the LIKE button - top left
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org to register
.
Hiç yorum yok:
Yorum Gönder